

MediCool Technologies, Inc.
MediCool is developing a painless way to treat dangerous cardiac arrhythmias and other disorders.
- Stage Product In Development
- Industry Medical Devices and Equipment
- Location Traverse City, MI, USA
- Currency USD
- Founded August 2015
- Employees 10
- Incorporation Type C-corp
- Website medicooltech.com
Company Summary
MediCool is developing a novel painless therapy for dangerous cardiac arrhythmias. We are initially focused on Post-operative A-Fib (POAF) a common, expensive and potentially morbid complication following cardiac surgery. MediCool’s approach, which has been successfully demonstrated in pre-clinical and First In Human trials, uses a cooling implant to painlessly terminate episodes of POAF while the patient is recovering from cardiac surgery.
Team
-
President & Chief Executive Officer
Proven commercial leader with over 20 years experience in CRM and A-Fib markets including 15 years at Boston Scientific and Guidant.
Commercialized multiple new devices and therapies. -
Chief Financial Officer
18 years of corporate finance and investment banking experience at Morgan Stanley, Wells Fargo and BNP Paribas
Advised 40+ M&A deals and led IPOs in excess of $15B
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.